title: Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study.
authors.affiliation: Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China; Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases, Xi'an 710021, China; Institute of Material Medical, School of Pharmacy, The Fourth Military Medical University, Xi'an 710032, China. Electronic address: yuqi6028@stu.xjtu.edu.cn.
authors.forename: Qi
authors.initials: Q
authors.lastname: Yu
authors.affiliation: Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China; Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases, Xi'an 710021, China.
authors.forename: Xingli
authors.initials: X
authors.lastname: Su
authors.affiliation: Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China; Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases, Xi'an 710021, China; Research Institute of Atherosclerotic Disease, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an, Shaanxi 710061, China.
authors.forename: Enqi
authors.initials: E
authors.lastname: Liu
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy* / Q000453:epidemiology*; D008297:Male
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Diabetes; Familial hypercholesterolemia; Low-density lipoprotein receptor; Statin